Literature DB >> 22909969

Heparin-like surface modification of polyethersulfone membrane and its biocompatibility.

Min Tang1, Jimin Xue, Kelin Yan, Tao Xiang, Shudong Sun, Changsheng Zhao.   

Abstract

Sulfonated polyethersulfone (SPES) and poly (acrylonitrile-co-acrylic acid-co-vinyl pyrrolidone) (P(AN-AA-VP)), which provided sulfonic acid (-SO(3)H) and carboxylic acid groups (-COOH), respectively, were used to modify polyethersulfone (PES) membrane with a heparin-like surface by blending method. The SPES was prepared by sulfonation of PES using chlorosulfonic acid as the sulfonating agent, while the P(AA-AN-VP) was prepared through a free radical polymerization. The PES and modified PES membranes were prepared by a phase-inversion technique; the modified membranes showed lowered protein (bovine serum albumin, BSA; bovine serum fibrinogen, FBG) adsorption and suppressed platelet adhesion. For the modified membranes, significant decreases in thrombin-antithrombin (TAT) generation, percentage platelets positive for CD62p expression, and the complement activation on C3a and C5a levels were observed compared with those for the pure PES membrane. Due to the similar negatively charged groups as heparin, the modified membranes effectively prolonged the activated partial thromboplastin time (APTT). Furthermore, the modified membranes showed good cytocompatibility. Hepatocytes cultured on the modified materials exhibited improved functional profiles in terms of scanning electron microscope (SEM) observation and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay compared with those on the pure PES membrane. It could be concluded that the modified membranes with sulfonic acid and carboxylic acid groups were endowed with excellent biocompatibility, and the heparin-like surface modification seemed to be a promising approach to improve the biocompatibility of materials.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909969     DOI: 10.1016/j.jcis.2012.07.076

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  4 in total

Review 1.  Historical Perspective and Future Direction of Blood Vessel Developments.

Authors:  Sashka Dimitrievska; Laura E Niklason
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

2.  Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis.

Authors:  Xiao Fu; Jian-Ping Ning
Journal:  J Mater Sci Mater Med       Date:  2018-05-09       Impact factor: 3.896

3.  From commodity polymers to functional polymers.

Authors:  Tao Xiang; Ling-Ren Wang; Lang Ma; Zhi-Yuan Han; Rui Wang; Chong Cheng; Yi Xia; Hui Qin; Chang-Sheng Zhao
Journal:  Sci Rep       Date:  2014-04-08       Impact factor: 4.379

4.  Surface hemocompatible modification of polysulfone membrane via covalently grafting acrylic acid and sulfonated hydroxypropyl chitosan.

Authors:  Ming-Ming Tu; Jing-Jie Xu; Yun-Ren Qiu
Journal:  RSC Adv       Date:  2019-02-21       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.